Roche’s RHHBY member company, Genentech, announced the FDA approval of TNKase (tenecteplase), a thrombolytic or ...

SOUTH SAN FRANCISCO, Calif., March 03, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® ...

GLP-1 drugs don’t appear to increase risk of suicide The drugs didn’t increase suicidal thoughts or actions among type 2 diabetics The study compared GLP-1 drugs against two other classes of ...

The rate of antiviral treatment in children and adolescents with influenza decreased between the 2017-2018 and 2023-2024 influenza seasons, including among those at increased risk for influenza ...

US president Andrew Jackson famously reacted to an unfavorable ruling by the Supreme Court chief justice with the defiant rejoinder: "John Marshall has made his decision, now let him enforce it ...

What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...

Heat affects wear and tear on the body, researchers say THURSDAY, Feb. 27, 2025 (HealthDay News) -- Exposure to extreme heat might accelerate aging in older adults, with sizzling weather causing them ...

J.P. Morgan analyst Richard Vosser maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of CHF230.00. The company’s shares closed yesterday at ...

Semaglutide is associated with a slightly increased risk of a potentially blinding eye condition People taking semaglutide had a 32% increased relative risk of NAION NAION causes sudden vision ...

Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...